Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Renzo J M, Riemens"'
Autor:
Renzo J. M. Riemens, Gunter Kenis, Jennifer Nolz, Sonia C. Susano Chaves, Diane Duroux, Ehsan Pishva, Diego Mastroeni, Kristel Van Steen, Thomas Haaf, Daniël L. A. van den Hove
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 24, p 15571 (2022)
A reoccurring issue in neuroepigenomic studies, especially in the context of neurodegenerative disease, is the use of (heterogeneous) bulk tissue, which generates noise during epigenetic profiling. A workable solution to this issue is to quantify epi
Externí odkaz:
https://doaj.org/article/66ae542e732043529e0d4cebcc6e8aaa
Autor:
Tim Vanmierlo, Niels Hellings, Daniel L.A. van den Hove, Patrick Vandormael, Assia Tiane, Jos Prickaerts, Renzo J. M. Riemens, Ben Rombaut, Melissa Schepers, Veerle Somers
Publikováno v:
Cellular and Molecular Life Sciences, 78(19-20), 6631-6644. Springer
Cellular and Molecular Life Sciences
Cellular and Molecular Life Sciences
The differentiation of oligodendrocyte precursor cells (OPCs) into myelinating oligodendrocytes is the prerequisite for remyelination in demyelinated disorders such as multiple sclerosis (MS). Epigenetic mechanisms, such as DNA methylation, have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d74c08df771e1f6852077c1d52b5201
https://lirias.kuleuven.be/handle/20.500.12942/720605
https://lirias.kuleuven.be/handle/20.500.12942/720605
Autor:
Silke Appenzeller, Andrea Gehrig, Barbara Altieri, Cristina L Ronchi, Sonja Steinhauer, Simone Rost, Silviu Sbiera, Juliane Lippert, Matthias Kroiss, Andreas Rosenwald, Martin Fassnacht, Clemens R. Mueller, Isabel Weigand, Raimunde Liang, Stefan Kircher, Renzo J. M. Riemens, Indrajit Nanda
Publikováno v:
Journal of Clinical Endocrinology & Metabolism, 103(12), 4511-4523. Oxford University Press
Context Adrenocortical carcinoma (ACC) has a heterogeneous prognosis, and current medical therapies have limited efficacy in its advanced stages. Genome-wide multiomics studies identified molecular patterns associated with clinical outcome. Objective
Autor:
Larissa Haertle, Cécile Cieuta-Walti, Tobias Müller, André Mégarbané, Per Hoffmann, Steffi G. Riedel-Heller, Daniel L. A. van de Hove, Thomas Haaf, Nady El Hajj, Marcus Dittrich, Michael Wagner, Sophie Durand, Renzo J. M. Riemens, Mathilde Roche, Roy Lardenoije, Clotilde Mircher, Anna Maierhofer, Aimé Ravel, Martin Scherer, Alfredo Ramirez, Markus Leber, Samantha Stora
Publikováno v:
Clinical Epigenetics
Clinical epigenetics 11(1), 195 (2019). doi:10.1186/s13148-019-0787-x
Clinical epigenetics, 11(1):195. BioMed Central Ltd
Clinical epigenetics 11(1), 195 (2019). doi:10.1186/s13148-019-0787-x
Clinical epigenetics, 11(1):195. BioMed Central Ltd
Abstract Background Trisomy 21 (T21) is associated with intellectual disability that ranges from mild to profound with an average intellectual quotient of around 50. Furthermore, T21 patients have a high risk of developing Alzheimer’s disease (AD)
Publikováno v:
Progress in Neurobiology
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Human pluripotent stem cell (PSC) technology and direct somatic cell reprogramming have opened up a promising new avenue in the field of neuroscience. These recent advances allow researchers to obtain virtually any cell type found in the human brain,
Publikováno v:
Advances in experimental medicine and biology. 978
Despite the enormous efforts of the scientific community over the years, effective therapeutics for many (epi)genetic brain disorders remain unidentified. The common and persistent failures to translate preclinical findings into clinical success are
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783319538884
Despite the enormous efforts of the scientific community over the years, effective therapeutics for many (epi)genetic brain disorders remain unidentified. The common and persistent failures to translate preclinical findings into clinical success are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99084e6f4a5ff59487bfe1a3a2bdd84b
https://doi.org/10.1007/978-3-319-53889-1_23
https://doi.org/10.1007/978-3-319-53889-1_23